Literature DB >> 27031477

"Missed" Mild Cognitive Impairment: High False-Negative Error Rate Based on Conventional Diagnostic Criteria.

Emily C Edmonds1, Lisa Delano-Wood1,2, Amy J Jak1,2, Douglas R Galasko1,2,3, David P Salmon3, Mark W Bondi1,2.   

Abstract

Mild cognitive impairment (MCI) is typically diagnosed using subjective complaints, screening measures, clinical judgment, and a single memory score. Our prior work has shown that this method is highly susceptible to false-positive diagnostic errors. We examined whether the criteria also lead to "false-negative" errors by diagnostically reclassifying 520 participants using novel actuarial neuropsychological criteria. Results revealed a false-negative error rate of 7.1%. Participants' neuropsychological performance, cerebrospinal fluid biomarkers, and rate of decline provided evidence that an MCI diagnosis is warranted. The impact of "missed" cases of MCI has direct relevance to clinical practice, research studies, and clinical trials of prodromal Alzheimer's disease.

Entities:  

Keywords:  Alzheimer’s disease; mild cognitive impairment; misclassification; misdiagnosis; neuropsychology

Mesh:

Substances:

Year:  2016        PMID: 27031477      PMCID: PMC4879874          DOI: 10.3233/JAD-150986

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  10 in total

1.  Subjective cognitive complaints contribute to misdiagnosis of mild cognitive impairment.

Authors:  Emily C Edmonds; Lisa Delano-Wood; Douglas R Galasko; David P Salmon; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2014-08-26       Impact factor: 2.892

Review 2.  Mild cognitive impairment as a clinical entity and treatment target.

Authors:  Ronald C Petersen; John C Morris
Journal:  Arch Neurol       Date:  2005-07

3.  Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors.

Authors:  Emily C Edmonds; Lisa Delano-Wood; Lindsay R Clark; Amy J Jak; Daniel A Nation; Carrie R McDonald; David J Libon; Rhoda Au; Douglas Galasko; David P Salmon; Mark W Bondi
Journal:  Alzheimers Dement       Date:  2014-05-22       Impact factor: 21.566

4.  Are empirically-derived subtypes of mild cognitive impairment consistent with conventional subtypes?

Authors:  Lindsay R Clark; Lisa Delano-Wood; David J Libon; Carrie R McDonald; Daniel A Nation; Katherine J Bangen; Amy J Jak; Rhoda Au; David P Salmon; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2013-04-03       Impact factor: 2.892

5.  Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates.

Authors:  Mark W Bondi; Emily C Edmonds; Amy J Jak; Lindsay R Clark; Lisa Delano-Wood; Carrie R McDonald; Daniel A Nation; David J Libon; Rhoda Au; Douglas Galasko; David P Salmon
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

6.  Absence of a relationship between subjective memory complaint and objective memory impairment in mild cognitive impairment (MCI): is it time to abandon subjective memory complaint as an MCI diagnostic criterion?

Authors:  Megan Elizabeth Lenehan; Shannon Zofia Klekociuk; Mathew James Summers
Journal:  Int Psychogeriatr       Date:  2012-05-01       Impact factor: 3.878

7.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

Authors:  Leslie M Shaw; Hugo Vanderstichele; Malgorzata Knapik-Czajka; Christopher M Clark; Paul S Aisen; Ronald C Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

8.  A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment.

Authors:  Alex J Mitchell
Journal:  J Psychiatr Res       Date:  2008-06-24       Impact factor: 4.791

9.  Quantification of five neuropsychological approaches to defining mild cognitive impairment.

Authors:  Amy J Jak; Mark W Bondi; Lisa Delano-Wood; Christina Wierenga; Jody Corey-Bloom; David P Salmon; Dean C Delis
Journal:  Am J Geriatr Psychiatry       Date:  2009-05       Impact factor: 4.105

10.  Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization.

Authors:  R C Petersen; P S Aisen; L A Beckett; M C Donohue; A C Gamst; D J Harvey; C R Jack; W J Jagust; L M Shaw; A W Toga; J Q Trojanowski; M W Weiner
Journal:  Neurology       Date:  2009-12-30       Impact factor: 9.910

  10 in total
  35 in total

1.  Resting State Abnormalities of the Default Mode Network in Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.

Authors:  Lisa T Eyler; Jeremy A Elman; Sean N Hatton; Sarah Gough; Anna K Mischel; Donald J Hagler; Carol E Franz; Anna Docherty; Christine Fennema-Notestine; Nathan Gillespie; Daniel Gustavson; Michael J Lyons; Michael C Neale; Matthew S Panizzon; Anders M Dale; William S Kremen
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

2.  Degree of cognitive impairment does not signify early versus late mild cognitive impairment: confirmation based on Alzheimer's disease polygenic risk.

Authors:  Jeremy A Elman; Eero Vuoksimaa; Carol E Franz; William S Kremen
Journal:  Neurobiol Aging       Date:  2020-06-11       Impact factor: 4.673

3.  Visual Object Discrimination Impairment as an Early Predictor of Mild Cognitive Impairment and Alzheimer's Disease.

Authors:  Leslie S Gaynor; Rosie E Curiel Cid; Ailyn Penate; Mónica Rosselli; Sara N Burke; Meredith Wicklund; David A Loewenstein; Russell M Bauer
Journal:  J Int Neuropsychol Soc       Date:  2019-08       Impact factor: 2.892

4.  Word-list intrusion errors predict progression to mild cognitive impairment.

Authors:  Kelsey R Thomas; Joel Eppig; Emily C Edmonds; Diane M Jacobs; David J Libon; Rhoda Au; David P Salmon; Mark W Bondi
Journal:  Neuropsychology       Date:  2018-02       Impact factor: 3.295

5.  Patterns of Cortical and Subcortical Amyloid Burden across Stages of Preclinical Alzheimer's Disease.

Authors:  Emily C Edmonds; Katherine J Bangen; Lisa Delano-Wood; Daniel A Nation; Ansgar J Furst; David P Salmon; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2016-11       Impact factor: 2.892

6.  MCI-to-normal reversion using neuropsychological criteria in the Alzheimer's Disease Neuroimaging Initiative.

Authors:  Kelsey R Thomas; Emily C Edmonds; Joel S Eppig; Christina G Wong; Alexandra J Weigand; Katherine J Bangen; Amy J Jak; Lisa Delano-Wood; Douglas R Galasko; David P Salmon; Steven D Edland; Mark W Bondi
Journal:  Alzheimers Dement       Date:  2019-09-05       Impact factor: 21.566

7.  Circulating Progenitor Cells Correlate with Memory, Posterior Cortical Thickness, and Hippocampal Perfusion.

Authors:  Daniel A Nation; Alick Tan; Shubir Dutt; Elissa C McIntosh; Belinda Yew; Jean K Ho; Anna E Blanken; Jung Yun Jang; Kathleen E Rodgers; Aimée Gaubert
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

8.  Using Base Rate of Low Scores to Identify Progression from Amnestic Mild Cognitive Impairment to Alzheimer's Disease.

Authors:  Javier Oltra-Cucarella; Miriam Sánchez-SanSegundo; Darren M Lipnicki; Perminder S Sachdev; John D Crawford; José A Pérez-Vicente; Luis Cabello-Rodríguez; Rosario Ferrer-Cascales
Journal:  J Am Geriatr Soc       Date:  2018-05-10       Impact factor: 5.562

9.  Faulty Adaptation to Repeated Face-Name Associative Pairs in Mild Cognitive Impairment is Predictive of Cognitive Decline.

Authors:  Sarah M Jurick; Gali H Weissberger; Lindsay R Clark; Christina E Wierenga; Yu-Ling Chang; Dawn M Schiehser; S Duke Han; Amy J Jak; Sheena I Dev; Mark W Bondi
Journal:  Arch Clin Neuropsychol       Date:  2018-03-01       Impact factor: 2.813

10.  The Montreal Cognitive Assessment: Is It Suitable for Identifying Mild Cognitive Impairment in Parkinson's Disease?

Authors:  Sara Rosenblum; Sonya Meyer; Netta Gemerman; Lilya Mentzer; Ariella Richardson; Simon Israeli-Korn; Vered Livneh; Tsvia Fay Karmon; Tal Nevo; Gilad Yahalom; Sharon Hassin-Baer
Journal:  Mov Disord Clin Pract       Date:  2020-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.